JPMorgan Chase & Co. Increases Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)
JPMorgan Chase & Co. increased its holdings in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 68.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 546,807 shares of the biopharmaceutical company’s stock after buying an additional 221,905 shares during the period. JPMorgan Chase & Co.’s holdings in MacroGenics were worth $1,777,000 as […]
JPMorgan Chase & Co. increased its holdings in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 68.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 546,807 shares of the biopharmaceutical company’s stock after buying an additional 221,905 shares during the period. JPMorgan Chase & Co.’s holdings in MacroGenics were worth $1,777,000 as […]
